HOME Research Insight Product Launches, Upgrades, and Approvals Accounted for the Largest Share of the Overall Growth Strategies Followed by Key Players in the Oligonucleotide Synthesis Market Between 2014 and 2017.



Product Launches, Upgrades, and Approvals Accounted for the Largest Share of the Overall Growth Strategies Followed by Key Players in the Oligonucleotide Synthesis Market Between 2014 and 2017.


The global oligonucleotide synthesis market is expected to reach USD 2.46 Billion by 2022 from USD 1.47 Billion in 2017 at a CAGR of 10.9%. This market is experiencing significant growth due to increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.

Product launches, upgrades, and approvals accounted for the largest share of the overall growth strategies followed by key players between 2014 and 2017. Some of the companies that adopted this strategy include IDT (US), Sigma-Aldrich Corporation (US) (part of Merck KGAA (Germany)), Eurofins Genomics (Germany), Thermo Fisher Scientific (US), Agilent Technologies (US), and GenScript (US).

The oligonucleotide synthesis market is fragmented nature with the presence of several large as well as emerging players. In 2016, Integrated DNA Technologies (IDT) (US), Sigma-Aldrich Corporation (US), Eurogentec (Belgium), Eurofins Genomics (Germany), Agilent Technologies (US), and Thermo Fisher Scientific (US) were the leading players in the oligonucleotide synthesis market. Other major players include BioAutomation (US), LGC Biosearch Technologies (US), GeneDesign (Japan), GE Healthcare (US), TriLink BioTechnologies (US), GenScript (China), Nitto Denko Avecia (US), ATDBio (UK), Bio-Synthesis (US), IBA GmbH (Germany), Gene Link (US), and AITbiotech (Singapore).

Thermo Fisher Scientific is one of the prominent players in the oligonucleotide synthesis market. The company’s wide product and service portfolio help it to maintain its position in the market. The company mainly focuses on product launches, approvals, and acquisitions as its key growth strategies to retain its position in this market. Some of the major acquisitions that assisted the company’s growth include that of Alfa Aesar (US) in June 2015 and Life Technologies Corporation (US) in February 2014. In the last few years, the company has launched various new products as well as enhanced its geographic presence. For instance, in 2017, it launched various products which include Applied Biosystems Axiom Africa Array, QuantStudio 5 Real-Time PCR System, and Ion AmpliSeq. It also established a new manufacturing facility in California, US, in October 2014. Such developments help the company to further enhance its presence and increase its share in the oligonucleotide synthesis market.

Integrated DNA Technologies is one of the major players in the oligonucleotide synthesis market. The leading position of this company is mainly attributed to its robust product portfolio and brand recognition in the market. The company pursues product launches as its key growth strategy. For instance, in July 2017, it launched the Alt-R S.p. HiFi Cas9 Nuclease 3NLS enzyme (Cas9 enzyme variant), enhancing genome editing. In February 2017, the company launched the Cpf1-based CRISPR genome editing system. It is the first genomics company to launch and develop a complete ribonucleoprotein-based Cpf1 CRISPR system, which enhanced its product portfolio and increased the options available to molecular biology researchers. Such developments help the company to retain its leading position in the oligonucleotide synthesis market.

Related Reports:

Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports